Antigenic mapping sheds light on SARS-CoV-2 immunity differences

A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.

Bausch + Lomb bulks up OTC business with J&J deal

Dive Brief: Bausch + Lomb continues to bulk up via dealmaking, announcing Thursday a deal to buy a line of eye and contact lens drops

July 7, 2023

StoryCatch Partners Acquires EmpiraMed

What You Should Know: – StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that

November 21, 2024

Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033 – Pharmaceutical Technology

Women accounted for approximately 73% of total prevalent Alzheimer’s cases in 2023. Credit: Antonio Marca / Shutterstock. Estimates by data analytics company GlobalData suggest that

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.